Abstract:Abstract There is evidence from epidemiologic data that cataract is more common in women than men. This is not solely due to a higher rate of cataract extraction in women, as is the case in the western world, but several population-based studies show that females have a higher prevalence of lens opacities, especially cortical. There is no firm evidence that lifestyle-related factors are the cause of this gender discrepancy. Focus has therefore been directed towards the role of estrogen in cataract formation. Although data on endogenous and exogenous estrogen involvement in cataractogenesis are conflicting, some studies have indicated that hormone therapy may decrease the risk of cataract and thus be protective. It has been hypothesized that the decrease in estrogen at menopause cause increased risk of cataract in women, i.e. not strictly the concentration of estrogen, but more the withdrawal effect. Estrogens are known to exert several anti-aging effects that may explain the longer lifespan in women, including metabolically beneficial effects, neuroprotection, preservation of telomeres and anti-oxidative properties. Since oxidative stress is considered important in cataractogenesis, studies have investigated the effects of estrogens on lens epithelial cells in culture or in animal models. Several investigators have found protection by physiological concentrations of 17β-estradiol against oxidative stress induced by H2O2 in cultured lens epithelial cells. Although both main types of estrogen receptors, ERα and ERβ, have been demonstrated in lens epithelium, most studies so far indicate that the estrogen-mediated protection in the lens is exerted through non-genomic, i.e. receptor-independent mechanisms, possibly through phosphorylation of extracellular signal-regulated kinase (ERK1/ERK2), a member of the mitogen-activated protein kinase (MAPK)-signaling pathway. Further studies are needed, both epidemiologic as to the role of hormone therapies, and laboratory studies regarding molecular estrogen-mediated mechanisms, in order to comprehend the role of estrogens on cataract formation.

A novel initiation codon mutation of PAX9 in a family with oligodontia

A Novel Missense Mutation in the Paired Domain of Human PAX9 Causes Oligodontia.

Gender and Cataract – The Role of Estrogen

Non-syndromic oligodontia with a novel mutation of PAX9

A novel G to A transition at initiation codon and exon-intron boundary of PAX9 identified in association with familial isolated oligodontia

[Patellectomy as a salvage operation].

Caring for organ donors: the intensive care unit physicians' view.

Novel PAX9 Mutations Causing Isolated Oligodontia

Identification and functional analysis of two novel PAX9 mutations.

A novel nonsense mutation in PAX9 is associated with sporadic hypodontia.

Identification and functional study of a novel variant of PAX9 causing tooth agenesis

Nitrate and nitrite in vegetables from areas affected by war-time operations in Croatia.

Mitotic Nondisjunction in the Case of Interchanges Involving the B-Type Chromosome in Maize.

Genotype-phenotype pattern analysis of pathogenic PAX9 variants in Chinese Han families with non-syndromic oligodontia

A Novel Axin2 Missense Mutation Is Associated With Non-Syndromic Oligodontia

Nine Novel PAX9 Mutations and a Distinct Tooth Agenesis Genotype-Phenotype.

Ginsenoside production, growth and cytogenetic characteristics of sustained Panax japonicus var. Repens cell suspension culture

Characterization of a PSE-4 Mutant with Different Properties in Relation to Penicillanic Acid Sulfones: Importance of Residues 216 to 218 in Class A β-Lactamases

Four Novel <i>PAX9</i> Variants and the <i>PAX9</i>-Related Non-Syndromic Tooth Agenesis Patterns

The phenotype and genotype of PAX9 mutations causing tooth agenesis

Novel missense mutations in the AXIN2 gene associated with non-syndromic oligodontia